跳至主要内容
临床试验/NCT06745141
NCT06745141招募中不适用

Oral Health Intervention Study in Patients with Myocardial Infarction and Periodontal Disease: a Simulated RCT Trial

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Changes in ejection fraction

研究概览

简要总结

The aim of this study is to establish a shared database of acute myocardial infarction patients with periodontitis, to clarify the clinical benefits of periodontitis intervention on acute myocardial infarction patients through simulated RCT study, and to establish a high-level database of acute myocardial infarction patients with periodontitis, so as to promote the application of oral health intervention in clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with ST-segment elevation myocardial infarction (STEMI). 2)Patients with severe periodontal disease, defined as:
  • 5 teeth with clinical attachment loss (CAL) ≥ 4 mm.
  • Subgingival probing depth (PD) ≥ 6 mm. ③≥ 8 teeth with gingival bleeding on probing (BOP). 3)Age ≥30 years. 4)Written informed consent provided.

排除标准

  • under 30 years old; 2) HIV positive, chronic inflammation, tumor disease, drug dependence, use of anticonvulsants, use of immunosuppressive agents, pregnancy, and lactation; 3) significant tooth loss (number of remaining teeth < 8); 4) long hospital stay (>10 days), new myocardial infarction before randomization, and stent thrombosis; 5) Refusal to sign informed consent.

结局指标

主要结局

Changes in ejection fraction

时间窗: From enrollment to the end of treatment at 6 months

The ejection fraction (EF) changed by 10% half a year after surgery

次要结局

  • Cardiovascular death and MACE events were recorded(From enrollment to the end of treatment at 6 months, a maximum of 12 months.)
  • level of proBNP(From enrollment to the end of treatment at 6 months)

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ya-Wei Xu

professor of medicine

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验